Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DMDO. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113214215B reveals a safer solid-phosgene route for olmesartan medoxomil intermediates. Discover cost reduction in API manufacturing and high-purity supply chain solutions.
Novel aqueous solvent method reduces impurities in Olmesartan Medoxomil synthesis ensuring supply chain reliability and cost effective pharmaceutical intermediates manufacturing.
Patent CN113214215A reveals a safer route for DMDO derivatives using solid phosgene and molecular distillation, offering reliable pharmaceutical intermediate supply.